IL183554A0 - Oral immediate formulation of a poorly watersoluble active substance - Google Patents

Oral immediate formulation of a poorly watersoluble active substance

Info

Publication number
IL183554A0
IL183554A0 IL183554A IL18355407A IL183554A0 IL 183554 A0 IL183554 A0 IL 183554A0 IL 183554 A IL183554 A IL 183554A IL 18355407 A IL18355407 A IL 18355407A IL 183554 A0 IL183554 A0 IL 183554A0
Authority
IL
Israel
Prior art keywords
active substance
oral immediate
immediate formulation
poorly watersoluble
poorly
Prior art date
Application number
IL183554A
Other versions
IL183554A (en
Original Assignee
Solvay Pharm Bv
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/056970 external-priority patent/WO2006067150A1/en
Application filed by Solvay Pharm Bv, Panacea Biotec Ltd filed Critical Solvay Pharm Bv
Publication of IL183554A0 publication Critical patent/IL183554A0/en
Publication of IL183554A publication Critical patent/IL183554A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL183554A 2004-12-23 2007-05-30 Oral immediate release formulation of a poorly water-soluble active substance IL183554A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63811104P 2004-12-23 2004-12-23
EP04106933 2004-12-23
PCT/EP2005/056970 WO2006067150A1 (en) 2004-12-23 2005-12-20 Oral immediate release formulation of a poorly watersoluble active substance

Publications (2)

Publication Number Publication Date
IL183554A0 true IL183554A0 (en) 2007-09-20
IL183554A IL183554A (en) 2011-07-31

Family

ID=35890662

Family Applications (1)

Application Number Title Priority Date Filing Date
IL183554A IL183554A (en) 2004-12-23 2007-05-30 Oral immediate release formulation of a poorly water-soluble active substance

Country Status (4)

Country Link
KR (1) KR20070104890A (en)
DE (1) DE602005019919D1 (en)
IL (1) IL183554A (en)
NO (1) NO20073728L (en)

Also Published As

Publication number Publication date
NO20073728L (en) 2007-07-18
KR20070104890A (en) 2007-10-29
DE602005019919D1 (en) 2010-04-22
IL183554A (en) 2011-07-31

Similar Documents

Publication Publication Date Title
HK1077218A1 (en) Oral solid solution formulation of a poorly water-soluble active substance
IL179279A0 (en) A biomolecule-containing formulation of increased stability
TWI369974B (en) Oral care implement
IL221199A (en) Pharmaceutical formulation comprising a scent
HK1131918A1 (en) Oral pharmaceutical formulations comprising salts of fenofibric acid
ZA200707022B (en) A solid pharmaceutical dosage formulation
HK1106987A1 (en) Oral care implement
HK1082392A1 (en) Oral care implement
ZA200703532B (en) Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
GB0426301D0 (en) Pharmaceutical formulations
SI1608362T1 (en) Stabilized pharmaceutical preparation comprising an amorphous active substance
IL213897A0 (en) Ultrasound contrast agent dosage formulation
PL1655026T3 (en) Solid pharmaceutical formulations comprising diacereine and meloxicam
PL1802329T3 (en) A pharmaceutical formulation comprising crystalline insulin and dissolved insulin
PL1848439T3 (en) Oral immediate release formulation of a poorly watersoluble active substance
GB0416397D0 (en) Pharmaceutical formulations
EP1755682A4 (en) Solid pharmaceutical formulation
ZA200610762B (en) A biomolecule-containing formulation of increased stability
IL183554A0 (en) Oral immediate formulation of a poorly watersoluble active substance
IS7290A (en) Pharmaceutical formulations containing risperidone
HK1122731A1 (en) Prolonged release formulation of active pharmaceutical ingredients
HK1111624A1 (en) Stable formulation comprising a moisture sensitve drug and manufacturing procedure thereof
ZA200705080B (en) Aminocarboxylic acid derivative and medicinal use thereof
GB0406048D0 (en) Drug formulations

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees